The well-described herpesvirus entry receptors HveA (TNFRSF14), HveB (nectin 2), and HveC (nectin 1) have been shown to mediate the entry of alphaherpesviruses. Our findings showed that the alphaherpesvirus equine herpesvirus 1 (EHV-1) efficiently entered and replicated in CHO-K1 cells that lack the entry receptors HveA, HveB, and HveC, demonstrating that EHV-1 utilizes a unique entry receptor. As with other alphaherpesviruses, efficient EHV-1 entry was dependent on glycoprotein D and cell surface glycosaminoglycans.
Equine herpesvirus 1 (EHV-1), a member of the Alphaherpesvirus subfamily, is the causative agent of respiratory distress, abortion, and neurological disease in horses (1) . Although many aspects of the virus life cycle have been very well characterized (15) , the early events in virus attachment and entry have not been systematically investigated. In particular, while entry receptors for several other alphaherpesviruses, including herpes simplex virus type 1 and 2 (HSV-1 and HSV-2), pseudorabies virus (PRV), and bovine herpesvirus 1 (BHV-1) have been identified, the ability of EHV-1 to use the same or different entry receptors is unknown.
HveA is a member of the tumor necrosis factor (TNF) receptor family and mediates entry of HSV-1 and HSV-2, but not PRV or BHV-1 (11) . HveC (nectin 1) belongs to the immunoglobulin superfamily and mediates entry of all of these alphaherpesviruses (6) . HveB, another immunoglobulin superfamily member, is also a receptor for PRV, HSV-2, and the Rid1 variant of HSV-1 (22) . In addition to HveA, HveB, and HveC, a modified form of heparan sulfate, 3-O-sulfated heparan sulfate, can mediate the entry of HSV-1 (17) . All of the receptors are recognized by glycoprotein D (gD) that in turn initiates the entry process (3, (7) (8) (9) 23) .
While a specific entry receptor has yet to be characterized for EHV-1, studies have shown that EHV-1 uses the same subset of viral glycoproteins utilized by other alphaherpesviruses for binding and entry into permissive cells. Similar to HSV-1, positively charged residues in EHV-1 gB and gC bind to heparan sulfate (HS) moieties on the cell surface (16, 19) . After initial attachment, EHV-1 gD is required for virus entry, but no description of its putative cognate receptor has been reported. In addition to gD, gB is also essential for virus penetration, growth, and cell-to-cell spread (13) . gH and gL are essential for HSV-1 and HSV-2 entry (12, 18, 20) , but whether these glycoproteins play a similar role in the EHV-1 entry pathway is unknown.
The aim of this study was to ascertain whether EHV-1 utilizes the same or novel entry receptor(s) compared with other well-characterized alphaherpesviruses. To this end, the infectivity of EHV-1 on a panel of cell lines that express different virus receptors was compared to the known infectivity patterns of other alphaherpesviruses. These cell lines included HSV-1-permissive cells CHO-A (HveA), CHO-C (HveC), and Vero, EHV-1-permissive rabbit kidney cell line RK13, and HSV-1-resistant cell lines CHO-K1 and J1.1-2. CHO-K1, CHO-A, CHO-C, RK13, and Vero cells were infected with a recombinant EHV-1 (L11⌬gI⌬gE), derived from the RacL11 strain, that expresses lacZ (5) , and the cells were stained with 5-bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal) 7 h postinfection (p.i.) to assess entry. L11⌬gI⌬gE efficiently entered RK13, CHO-K1, CHO-A, and CHO-C cells but exhibited severely impaired entry into Vero cells (Fig. 1A) . In contrast, an HSV-1 recombinant that expresses lacZ (QOZHG) (2) did not infect CHO-K1 cells but efficiently entered all other cell lines that express at least one of the HSV-1 entry receptors (Fig. 1B) . At the same multiplicity of infection (MOI), L11⌬gI⌬gE was further shown to enter another HSV-resistant cell line, J1.1-2 (Fig. 1C) , as well as HSV-1-resistant CHO-B (HveB) cells (data not shown). An EHV-1 recombinant derived from the KyA strain, KyA⌬gp2 (21), also efficiently entered CHO-K1 and J1.1-2 cells (data not shown). These data showed that EHV-1 entry into cells is independent of any of the known alphaherpesvirus receptors. In addition, the ability of two EHV-1 strains to efficiently enter two different HSV-resistant cell lines, CHO-K1 and J1.1-2, suggests a common mechanism for EHV-1 entry into these cells which is not strain specific. However, from these data, it is unclear whether EHV-1 is utilizing one common entry receptor or two different receptors on these cells.
Previous studies by Csellner et al. showed that EHV-1 gD is essential for EHV-1 entry into permissive RK13 cells (4) . To examine whether EHV-1 gD is required for entry into HSV receptor-negative cells, CHO-K1 cells were infected with a gD-null virus EHV-1⌬gD (derived from the HVS25A strain) (4). Complemented EHV-1⌬gD was passed through noncomplementing RK13 or EHV-1 gD-expressing RK13 (RKgD) cells, and clarified infected-cell lysates were used to infect CHO-K1, Vero, or RK13 cells. As shown in Fig. 2, gD- . These data supported the conclusion that gD is required for efficient entry of EHV-1 into HSV receptor-negative cells.
In addition to gD, efficient EHV-1 entry also required the expression of glycosaminoglycans (GAGs), since CHO-K1 cells deficient in GAG synthesis (pgsA745) (10) were poorly infected with EHV-1 after a 2-h attachment phase (Fig. 3) . However, the presence of cell surface GAGs was not sufficient for entry, since GAG-expressing Vero cells were highly resistant to EHV-1 infection. Entry of EHV-1 into CHO-K1 cells occurred rapidly, and the kinetics of EHV-1 entry into CHO-K1 cells were similar to that of EHV-1 on the standard permissive host cell line, RK13 (Fig. 3) . These data corroborate previous work showing that GAG receptor binding is essential for efficient alphaherpesvirus entry (16, 18, 19) .
To assay the ability of EHV-1 to replicate in CHO cells, a one-step growth assay was performed. CHO-K1, CHO-A, CHO-C, Vero, or RK13 cells were infected with L11⌬gI⌬gE at an MOI of 1 (Fig. 4) . Cells were washed with acidic buffer at 2 h p.i., and the titers of supernatants harvested at various time points were determined in RK13 cells. At 8 h p.i., the virus titers were similar for CHO-K1, CHO-A, and CHO-C cells, while the titers in Vero cells were reduced 533-fold compared to those in CHO-K1 cells. The reduced titers in Vero cells at early time points corresponded with the decreased entry kinetics of EHV-1 in Vero cells (Fig. 3) ; however, there was no postentry block to replication after EHV-1 entry in these cells. EHV-1 titers in RK13 cells reached a maximum of 3.27 ϫ 10 7 PFU/ml at 48 h p.i. Compared to EHV-1 titers in RK13 cells, EHV-1 titers in CHO-K1 cells were reduced 72-fold, reaching a maximum of 4.53 ϫ 10 5 PFU/ml at 48 h p.i. The maximum titers in Vero cells were reduced 744-fold compared to titers in RK13 cells and were reduced 10-fold compared to titers in CHO-K1 cells. These data show that EHV-1 can productively replicate and produce progeny virus in CHO-K1 cells.
Interestingly, PRV and HSV-2 were previously shown to enter CHO-K1 cells (14, 24) . However, entry into these cells was greatly enhanced when one of the alphaherpesvirus receptors was expressed (6, 14) . Future studies will examine whether the entry receptor utilized by EHV-1 on CHO-K1 cells is similar or distinct from the receptor(s) recognized by HSV-2 and PRV.
In summary, EHV-1 entry is mediated by an uncharacterized receptor that is distinct from all of the previously identified alphaherpesvirus receptors. EHV-1 entry into HSV-resistant cells is dependent upon gD expression, and entry is greatly enhanced in cells that express GAGs. Current experiments are aimed at identifying the EHV-1 entry receptor or receptors.
